kenvue inc shares kvue were cheered in their wall street debut thursday as the johnson  johnson jnj spinoff with consumer brands including tylenol bandaid and listerine saw it’s stock open 160 above its initial public offering price kenvue raised 38 billion as it said late wednesday that it sold 1728 million shares in the ipo up from previous expectations of 1512 million shares at 22 a share which was at the higher end of the expected pricing range of between 20 and 23 a share with 187 billion shares outstanding after the ipo the pricing values the company at 4108 billion the stock’s first trade was at 2553 at 1247 pm eastern for 157 million shares at the opening price the company was valued at 4767 billion shares of jj which owns 172 billion kenvue shares or 919 of the shares outstanding slipped 05 in midday trading kenvue’s debut comes at a time when the ipo market had all but dried up and investors haven’t been showing shares of recent ipos much love the renaissance ipo exchangetraded fund ipo has lost 77 over the past three months while the sp 500 spx has slipped 18